Prediction and validation of murine MHC class I epitopes of the recombinant virus VSV-GP

Oncolytic viruses are currently tested as a novel platform for cancer therapy. These viruses preferentially replicate in and kill malignant cells. Due to their microbial origin, treatment with oncolytic viruses naturally results in anti-viral responses and general immune activation. Consequently, th...

Descripción completa

Detalles Bibliográficos
Autores principales: Vijver, Saskia V., Danklmaier, Sarah, Pipperger, Lisa, Gronauer, Raphael, Floriani, Gabriel, Hackl, Hubert, Das, Krishna, Wollmann, Guido
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9893851/
https://www.ncbi.nlm.nih.gov/pubmed/36741416
http://dx.doi.org/10.3389/fimmu.2022.1100730

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9893851/
https://www.ncbi.nlm.nih.gov/pubmed/36741416
http://dx.doi.org/10.3389/fimmu.2022.1100730

Ejemplares similares